| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2587 | Holothurin A | Natural inhibitor of dietary fat absorption and showing strong anti-obesity activity |
|
| DCC2588 | Homochlorcyclizine Dihydrochloride | Histamine H1 receptor antagonist |
|
| DCC2589 | Homovanillyl Sinapate | Novel c-Met inhibitor, markedly reducing tumor growth, showing excellent pharmacodynamics, and suppressing cell proliferation and microvessel density in an orthotopic model of triple negative breast cancer |
|
| DCC2590 | Hpta-1 | Novel highly selective switch-on fluorescence sensor, targeting telomeric dimeric G-quadruplex, discriminating the telomeric dimeric G-quadruplex TTA45 against other types of DNA structures accompanied by a drastic enhancement of the emission intensity wi |
|
| DCC2591 | Hpxr-agonist-28 | Novel silanol-based human pregnane X receptor (PXR) agonist |
|
| DCC2592 | Hr1405-01 | Loxoprofen active metabolite, acting as a safe intravenous NSAID with superior anti-inflammatory and analgesic activities |
|
| DCC2593 | Hras-1y I-motif Probe-1 | Novel Probe of the hras-1Y i-motif , selectively and directly interacting with the hras-1Y i-motif. |
|
| DCC2594 | Hrv-14 Inhibitor 3v | Inhibitor of human rhinoviruses serotype 14 (HRV-14) |
|
| DCC2595 | Hs-438 | Novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia |
|
| DCC2596 | Hs-731 | μ-Opioid Receptor Agonist |
|
| DCC2597 | Hsa-5b | Novel anticancer Gold(III) agent with remarkable cytotoxicity to gastric cancer cells |
|
| DCC2598 | Hsd1237 | Novel potent inhibitor of the recombinant FLT3 kinase and its mutant forms, blocking the proliferation of AML cell lines, harboring oncogenic FLT3-ITD mutations with remarkable IC50 values, which were comparable to the approved FLT3 inhibitor quizartinib, |
|
| DCC2599 | Hsgn-94 | Novel inhibitor of lipoteichoic acid (LTA) biosynthesis, potently inhibiting S. aureus and E. faecalis growth and biofilm formation |
|
| DCC2600 | Hsk21542 | Novel Peripherally-Restricted Kappa Opioid Receptor (KOR) Agonist with Antinociceptive and Antipruritic Effects |
|
| DCC2601 | Hsp27-in-i | Novel inhibitor of heat shock 27 kDa protein (HSP27), significantly inducing AR degradation in GBM cells via the proteasomal pathway, selectively inhibiting AR-overexpressed GBM cell growth with IC 50 values around 5 nM |
|
| DCC2602 | Hsp90-aha1 Inhibitor A16 | Novel Hsp90-Aha1 chaperone complex formation inhibitor, enhancing F508del-CFTR channel activity |
|
| DCC2603 | Hsp90-in-30f | Novel potent inhibitor of heat shock protein 90 (Hsp90), effectively reducing the expression levels of Hsp90 client proteins including Her2, EGFR, Met, Akt, and c-Raf |
|
| DCC2604 | Hsp90-in-89 | Novel heat shock protein 90 (Hsp90) inhibitor |
|
| DCC2605 | Hsp90-in-s89 | Novel heat shock protein 90 (Hsp90), more potent enantiomer |
|
| DCC2606 | Htl0028016 | Novel macrocyclic calcitonin gene-related peptide (CGRP) receptor antagonist |
|
| DCC2607 | Htl0028125 | Novel macrocyclic calcitonin gene-related peptide (CGRP) receptor antagonist |
|
| DCC2608 | Htl26119 | Novel allosteric antagonist of the glucagon-like peptide-1 receptor (GLP-1R) |
|
| DCC2609 | Htl6641 | Novel, potent, selective, and orally efficacious dual antagonist of the orexin receptors |
|
| DCC2610 | hts05737 | Novel activator of PC2 |
|
| DCC2611 | Huhs029 | Novel analgesic agent, activating TRPA1 and subsequently desensitizing the channel, exhibiting higher inhibitory activity than resveratrol |
|
| DCC2612 | Human Vitronectin (351-359) | Adhesive peptide (sequence 351-359 mapped on the Human Vitronectin Protein), covalent and selective functionalizing on glass and titanium surfaces, increasng osteoblast attachment and adhesion strength and to promoting osseointegration |
|
| DCC2613 | Hur-ligand-4 | Novel human antigen R (HuR) ligand, acting as a HuR-RNA interferer |
|
| DCC2614 | Hy1-pt | Novel CK2-Specific Pt(II) Compound, Reversing Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments |
|
| DCC2615 | Hycanthone Mesylate | Inhibitor of apurinic endonuclease-1 (APE1) by direct protein binding |
|
| DCC2616 | Hydro-1080 | Activable Probe for Noninvasive Hydroxyl Radical Imaging, emitted in 1000-1400 nm after responding to ·OH |
|
